InvestorsHub Logo
Followers 7
Posts 1940
Boards Moderated 0
Alias Born 04/10/2016

Re: flipper44 post# 95726

Sunday, 01/15/2017 10:32:56 AM

Sunday, January 15, 2017 10:32:56 AM

Post# of 706527
"It's clearly an rGBM trial, but they have not removed the "lung" language. Plenty of time to do so once alerted. I simply don't get it."

My guess is that it is a different version of the vaccine than what we are used to seeing that UCLA is using for this trial. Probably not a mistake.

UCLA owns the technology. They licensed certain aspects to Cognate for manufacturing purposes. NWBIO was previously the financing mechanism for the trials, but that isn't necessary any longer as evidenced by the most recently announced trials. They have been constructed in such a way to be able to continue without the existence of NWBIO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News